Mirae Asset Global ETFs Holdings
XFOR icon

Mirae Asset Global ETFs Holdings’s X4 Pharmaceuticals XFOR Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,356
Closed -$23.8K – 3263
2025
Q1 		$23.8K Buy
3,356
+143
+4% +$1.97K ﹤0.01% 2965
2024
Q4 		$70.7K Buy
3,213
+137
+4% +$2.18K ﹤0.01% 2826
2024
Q3 		$61.8K Buy
3,076
+961
+45% +$20.1K ﹤0.01% 2876
2024
Q2 		$36.8K Buy
+2,115
New +$69.2K ﹤0.01% 2850

Other funds holding XFOR

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's XFOR Position: Q2 2025 in Review

Mirae Asset Global ETFs Holdings sold out of X4 Pharmaceuticals (XFOR) in Q2 2025, closing a stake of 3,356 shares — an estimated $23.8K sold.

Mirae Asset Global ETFs Holdings first reported a position in XFOR in Q2 2024 and held it in 4 quarters. The position peaked at $70.7K in Q4 2024. 51 funds tracked by Wall St. Rank hold XFOR as of Q2 2025.

  • Mirae Asset Global ETFs Holdings reported no remaining X4 Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Mirae Asset Global ETFs Holdings sold 3,356 X4 Pharmaceuticals shares in Q2 2025, an estimated $23.8K.
  • Mirae Asset Global ETFs Holdings first reported a position in X4 Pharmaceuticals in Q2 2024 and held it in 4 quarters.
  • Mirae Asset Global ETFs Holdings's X4 Pharmaceuticals position peaked at $70.7K in Q4 2024.
  • 51 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q2 2025.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2025, filed 14 Aug 2025.